Morris Capital Advisors’s Gilead Sciences GILD Stock Holding History

Morris Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-45,738	Closed	-$3.45M	–	75
2018 Q1	$3.45M	Buy	45,738 +393	+0.9%	+$31.2K	2.28%	22
2017 Q4	$3.25M	Sell	45,345 -3,641	-7%	-$276K	2.12%	25
2017 Q3	$3.97M	Sell	48,986 -848	-2%	-$64.8K	2.65%	19
2017 Q2	$3.53M	Sell	49,834 -2,220	-4%	-$148K	2.49%	20
2017 Q1	$3.54M	Sell	52,054 -5,177	-9%	-$364K	2.57%	21
2016 Q4	$4.1M	Sell	57,231 -9,765	-15%	-$726K	2.85%	17
2016 Q3	$5.3M	Sell	66,996 -6,821	-9%	-$554K	3.29%	8
2016 Q2	$6.16M	Buy	73,817 +10,322	+16%	+$916K	3.66%	7
2016 Q1	$5.83M	Buy	63,495 +1,334	+2%	+$120K	3.95%	4
2015 Q4	$6.29M	Buy	+62,161	New	+$6.47M	4.38%	2

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morris Capital Advisors's GILD Position: Q2 2018 in Review

Morris Capital Advisors sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 45,738 shares — an estimated $3.45M sold.

Morris Capital Advisors first reported a position in GILD in Q4 2015 and held it in 10 quarters. The position peaked at $6.29M in Q4 2015. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

Morris Capital Advisors reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
Morris Capital Advisors sold 45,738 Gilead Sciences shares in Q2 2018, an estimated $3.45M.
Morris Capital Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 10 quarters.
Morris Capital Advisors's Gilead Sciences position peaked at $6.29M in Q4 2015.
1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Morris Capital Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.